Prophylactic treatment of depression induced by interferon-α

Psychosomatics

Volumn 41, Issue 5, 2000, Pages 439-441

  Hauser, Peter ^a,b,c   Soler, Rosa ^a,b,c   Reed, Susan ^a,b,c   Kane, Robert ^a,b,c   Gulati, Mangla ^a,b,c   Khosla, Jaswinder ^a,b,c   Kling, Mitchel A ^a,b,c   Valentine, Alan D ^a,b,c   Meyers, Christina A ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; FLUOXETINE; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DEPRESSION; DRUG WITHDRAWAL; HUMAN; INSOMNIA; MALE; PROPHYLAXIS;

EID: 0033851950     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.41.5.439     Document Type: Letter

References (12)

1. Interferon alpha II-B: Adjuvant therapy of high risk resected cutaneous melanoma. Focal and cooperative oncology group trial EST 1684
2. Interferon alpha-2b alone or in combination with ribavirin as the initial treatment for chronic hepatitis C
3. Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer
4. Psychiatric complications of long-term interferon alfa therapy
5. Central nervous system toxicity of biological response modifiers
6. Mood and cognitive side effects of interferon alpha therapy
7. Cytokines and brain function: Relevance to interferon-alpha-induced mood and cognitive changes
8. Fluoxetine treatment of depression caused by interferon-alpha
9. Successful treatment of interferon alpha-induced mood disorder with nortryptyline
10. Treatment of neurotoxic side effects of IFN-a with naltrexone